Thông tin cho nhân viên y tế
Thuốc mới và thông tin từ Drugs.com
- Paris, July 10, 2026. The US Food and Drug Administration (FDA) has approved subcutaneous (SC) Sarclisa (isatuximab-irfc) Escena in combination with standard-of-care regimens for the treatment of patients with multiple myeloma (MM) across all…
- RALEIGH, N.C., July 9, 2026 /PRNewswire/ — Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and central nervous system (CNS) therapies, announced today that the…
- PARAMUS, N.J., July 8, 2026 /PRNewswire/ — On July 2, 2026, the U.S. Food and Drug Administration (FDA) approved the use of wilate® (von Willebrand Factor/Coagulation Factor VIII Complex [Human]) for routine prophylaxis to reduce the frequency…
- BRISBANE, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Trutakna (atacicept-vymj) accelerated…
- BOSTON–(BUSINESS WIRE)–Jul. 1, 2026– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved expanded use of Casgevy (exagamglogene autotemcel) for the treatment of people…
- MENLO PARK, CA, June 30, 2026 – Orca Bio, a commercial-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the U.S. Food and Drug Administration (FDA) has approved…
- MONDAY, July 13, 2026 — Variation is seen in the prevalence and patterns of risk factors for dementia, but broadly similar clusters of risk factors are observed across countries and regions, according to a study published online July 12 in The…
- MONDAY, July 13, 2026 — National Football League (NFL) athletes have higher neurodegenerative mortality than the general population, according to a study published online July 8 in eClinicalMedicine.Charlotte B. Luster, from the Spaulding…
- MONDAY, July 13, 2026 — Most U.S. adults using social media report some health-related engagement with social media, according to a research letter published online June 30 in the Journal of the American Medical Association. Aline F. Pedroso…
- MONDAY, July 13, 2026 — The configuration of the initial pure tone audiogram is an independent predictor of complete recovery in idiopathic sudden sensorineural hearing loss (ISSNHL), according to a study published online June 17 in…
- MONDAY, July 13, 2026 — Higher coffee consumption is associated with favorable indicators of liver health, according to a study published online July 1 in Clinical Gastroenterology and Hepatology. Hyun-Seok Kim, from Cedars-Sinai Medical Center in…
- MONDAY, July 13, 2026 — Lung transplantation can prolong survival for select patients with medically refractory, lung-limited, stage IV non-small cell lung cancer (NSCLC), according to a study published online July 8 in the Journal of the American…
Thông tin từ The Pharma Letter
- US clinical-stage biotech Q32 Bio saw its shares rocket almost 64% to $18.37 by mid-morning, after it announced positive 36-week top-line results from Part B of its SIGNAL-AA Phase IIa clinical trial evaluating bempikibart in patients with severe or very severe alopecia areata (AA).
- Japanese drugmaker Eisai today announced the latest findings on etalanetug (development code: E2814) showed that this investigational anti-MTBR antibody reduced levels of plasma eMTBR-tau243, a key biomarker of Alzheimer's disease (AD) tau tangle pathology.
- US pharma major Pfizer has changed the leadership of its obesity discovery group, with Danna Breen appointed vice president and head of obesity discovery following the departure of longtime scientific leader Kendra Bence.
- US RNA medicines focused biotech Stoke Therapeutics today announced that Thomas McCauley has been appointed chief scientific officer (CSO).
- UK pharma major GSK today announced positive interim results from the registrational phase II AZUR-1 trial of Jemperli (dostarlimab) in patients with stage II/III mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) locally advanced rectal cancer.
- Japan-based Global Health Innovative Technology Fund has committed around 2.86 billion yen ($18 million) to six R&D projects targeting malaria, tuberculosis and neglected tropical diseases.
Thông tin từ BioPharmaDive
- The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analysts said.
- Nearly two years after clinical setbacks cratered Q32’s stock price, new results showed hair growth improvements that surpassed investors’ expectations.
- Agenus is financially abandoning an ongoing study in late-line colorectal cancer. Elsewhere, an ebola vaccine began human testing and an important Bristol Myers medicine got an FDA decision date.
- Though funding totals represented the highest first-half sum since the start of 2022, industry watchers are concerned that small startups are being left behind.
- This podcast explores how clinical trial supplies move from early planning to global delivery, ensuring investigational medicines reach patients safely and on time.
- GSK claimed the result was a first for an ADC aimed at the “B7-H3” protein, an increasingly popular target of late among cancer drugmakers.
Thông tin từ STAT News
- A group of AIDS activists obtained an R&D pact at the heart of a settlement between the U.S. government and Gilead Sciences over patents for HIV prevention.
- A dementia prevention trial praised as a "landmark" effort further demonstrated the promise of structured programs tailored to local cultures.
- UnitedHealth touts a new home care audit, and more health insurers sue CMS over Medicare Advantage quality ratings.
- Martha Lillard, last U.S. polio patient using iron lung, has died at 78 in Oklahoma.
- The year of daraxonrasib, a wearable for a myeloma drug, and more biotech news from The Readout
- U.S. health secretary Robert F. Kennedy Jr. is pressing forward with his effort to help Americans stop taking SSRI antidepressants
Thông tin từ Nature Review Drug Discovery
- Nature Reviews Drug Discovery, Published online: 13 July 2026; doi:10.1038/s41573-026-01481-9Simulation-guided clinical trial design can enable identification of the optimal design to bring safe and effective therapies to patients as efficiently as possible, and it is particularly useful when exploring innovative strategies such as adaptive designs and master protocols. This Perspective discusses the value of trial […]
- Nature Reviews Drug Discovery, Published online: 10 July 2026; doi:10.1038/d41573-026-00120-7FDA new drug approvals in Q2 2026
- Nature Reviews Drug Discovery, Published online: 09 July 2026; doi:10.1038/s41573-026-01484-6Addressing challenges in treating rare tumours: the strategy of China’s National Cancer Center
- Nature Reviews Drug Discovery, Published online: 08 July 2026; doi:10.1038/d41573-026-00117-2CAR T cell therapy for solid cancer scores first approval in China
- Nature Reviews Drug Discovery, Published online: 08 July 2026; doi:10.1038/d41573-026-00119-0FDA approves novel cell therapy made with haematopoietic stem cells, Tregs and T cells
- Nature Reviews Drug Discovery, Published online: 08 July 2026; doi:10.1038/d41573-026-00118-1FDA approves second IGF-1R-targeted antibody for thyroid eye disease